Haplo-HSCT for Myelofibrosis
- Status
- RECRUITING
- Phase
- NA
Clinical Trials Related to Myelofibrosis
Related studies linked through entity extraction aliases.
A Phase 2 Study of INCB57643 (BET Inhibitor) in Combination With Ruxolitinib in JAK Inhibitor-naïve Patients With Myelofibrosis
- Status
- WITHDRAWN
- Phase
- PHASE2
Tasquinimod in Patients with Myelofibrosis Refractory to or Intolerant for JAK2 Inhibition
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
To Evaluate the Pharmacokinetics and Safety of TQ05105 Tablet in Renal Impairment Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Epidemiology in Contemporary Patients With Myelofibrosis.
- Status
- RECRUITING
- Phase
- N/A
Ruxolitinib in Primary Myelofibrosis and Secondary to Essential Thrombocythemia or Polycythemia Vera
- Status
- RECRUITING
- Phase
- N/A
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
- Status
- RECRUITING
- Phase
- PHASE3
Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
RVU120 in Patients With Intermediate or High-risk, Primary or Secondary Myelofibrosis
- Status
- RECRUITING
- Phase
- PHASE2
TQ05105 Tablet for Myelofibrosis Treatment in Ruxolitinib-Resistant or Intolerant Patients
- Status
- TERMINATED
- Phase
- PHASE1
A Study of GLB-001 in Patients With Myeloid Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)
- Status
- RECRUITING
- Phase
- PHASE3
High Dose Ruxolitinib and Allogeneic Stem Cell Transplantation in Myelofibrosis Patients With Splenomegaly
- Status
- RECRUITING
- Phase
- PHASE2
A Clinical Trial of TQ05105 Tablets Combined With TQB3909 Tablets in the Treatment of Myelofibrosis (MF)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
18F-FAPI PET/MRI Imaging in Myelofibrosis: a Prospective Observational Study.
- Status
- RECRUITING
- Phase
- N/A
Comparative Study on Pharmacokinetics of Two Formulations of Jaktinib in Healthy Adults Under Fasting Conditions
- Status
- COMPLETED
- Phase
- PHASE1
A Clinical Trial of TQ05105 Tablets Combined With TQB3617 Capsules in the Treatment of Myelofibrosis (MF)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms
- Status
- RECRUITING
- Phase
- PHASE2
CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Evaluate Drug-Drug Interaction of TQ05105 Tablets
- Status
- COMPLETED
- Phase
- PHASE1